Novo Nordisk shares rise after Wegovy recommended by Britain's drug price regulator

The new recommendation will significantly expand access to Wegovy on the England's NHS.

By CNBC · CNBC

The new recommendation will significantly expand access to Wegovy on the England's NHS.